Value
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 4.5 |
| P/S | 8.3 |
| EV/EBITDA | 4.3 |
| Fwd P/E | 8.4 |
| PEG | 7.6 |
| Analyst target | 5.0 |
- ▸Forward P/E: 13.8x
- ▸PEG: 0.90
ALGN · Why this verdict
Why Align Technology (ALGN) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.4/10
ConfidenceHIGH
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Align Technology has delivered 3 consecutive quarterly earnings beats averaging roughly 10% above estimates and converts 125% of net income into free cash flow, but the stock is near its analyst consensus target with just 2% upside remaining and an unfavorable reward-to-risk ratio; elevated put-to-call activity and 80% product concentration in the clear aligner segment limit the near-term conviction case.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Approximately 80% of revenues are tied to the clear aligner segment, creating concentrated exposure to a single product category; any sustained shift in orthodontic treatment volumes or competitive pricing pressure in that segment would have outsized impact on overall results. Bear case | If diversification proceeds, the non-aligner segment should grow to represent more than 25% of total revenue within 12 months. | →Stable |
| CounterDeep focus on a single high-value product can generate manufacturing scale and brand pricing power; the concentration may reflect a defensible market position rather than a structural liability. | ||
The company has beaten analyst earnings estimates in each of the 3 most recent quarters, with average positive surprises of roughly 10%, demonstrating a track record of managing and beating investor expectations consistently. Earnings | EPS surprises should remain positive for the next 2 consecutive quarters to confirm the execution trend is intact. | →Stable |
| CounterThe fourth-oldest reported quarter produced a miss of 3.3%, and 80% revenue concentration in a single product segment means any demand deceleration in that segment could break the beat streak abruptly. | ||
The business converts 125% of net income into free cash flow, indicating that reported earnings likely understate the true economic cash the business generates; this quality advantage supports balance-sheet optionality for buybacks or debt reduction. Quality breakdown | The free-cash-flow-to-net-income ratio should remain above 100% for the next 12 months to validate that the conversion premium is structural rather than one-time. | →Stable |
| CounterWith a debt-to-equity ratio of 2.8, a meaningful share of operating cash flow may need to be directed toward servicing and reducing financial obligations, which could compress free cash flow headroom over time. | ||
With approximately 2% remaining to the analyst consensus price target and a put-to-call ratio of 1.36 indicating above-average bearish options positioning, the near-term reward-to-risk geometry does not support new entry at current levels. Price targets | If the setup improves, analyst targets should be revised so that consensus upside exceeds the current price by more than 10%, and the put-to-call ratio should decline below 0.80. | →Stable |
| CounterPrice momentum remains intact — the stock is above all moving averages with a bullish MACD signal and rising on-balance volume — and a strong upcoming quarter could prompt immediate analyst upgrades that widen the upside gap. | ||
Approximately 80% of revenues are tied to the clear aligner segment, creating concentrated exposure to a single product category; any sustained shift in orthodontic treatment volumes or competitive pricing pressure in that segment would have outsized impact on overall results.
→StableBear case
- Expectation
- If diversification proceeds, the non-aligner segment should grow to represent more than 25% of total revenue within 12 months.
CounterDeep focus on a single high-value product can generate manufacturing scale and brand pricing power; the concentration may reflect a defensible market position rather than a structural liability.
The company has beaten analyst earnings estimates in each of the 3 most recent quarters, with average positive surprises of roughly 10%, demonstrating a track record of managing and beating investor expectations consistently.
→StableEarnings
- Expectation
- EPS surprises should remain positive for the next 2 consecutive quarters to confirm the execution trend is intact.
CounterThe fourth-oldest reported quarter produced a miss of 3.3%, and 80% revenue concentration in a single product segment means any demand deceleration in that segment could break the beat streak abruptly.
The business converts 125% of net income into free cash flow, indicating that reported earnings likely understate the true economic cash the business generates; this quality advantage supports balance-sheet optionality for buybacks or debt reduction.
→StableQuality breakdown
- Expectation
- The free-cash-flow-to-net-income ratio should remain above 100% for the next 12 months to validate that the conversion premium is structural rather than one-time.
CounterWith a debt-to-equity ratio of 2.8, a meaningful share of operating cash flow may need to be directed toward servicing and reducing financial obligations, which could compress free cash flow headroom over time.
With approximately 2% remaining to the analyst consensus price target and a put-to-call ratio of 1.36 indicating above-average bearish options positioning, the near-term reward-to-risk geometry does not support new entry at current levels.
→StablePrice targets
- Expectation
- If the setup improves, analyst targets should be revised so that consensus upside exceeds the current price by more than 10%, and the put-to-call ratio should decline below 0.80.
CounterPrice momentum remains intact — the stock is above all moving averages with a bullish MACD signal and rising on-balance volume — and a strong upcoming quarter could prompt immediate analyst upgrades that widen the upside gap.
Per-dimension breakdown
Quality
6.1/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 3.6 |
| ROA | 4.9 |
| Gross margin | 10.0 |
| Op margin | 6.6 |
| Net margin | 5.2 |
| Current ratio | 5.2 |
| FCF quality | 9.2 |
| Moat | 5.8 |
| Rule of 40 | 3.0 |
| Piotroski F | 7.8 |
- ▸Excellent cash conversion: 125% FCF/NI
- ▸Rule of 40: 19 (fail)
- ▸Strong Piotroski F-Score: 7/9
Growth
5.4/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 4.0 |
| EPS growth | 6.8 |
Momentum
4.8/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.5 |
| MACD | 8.4 |
| OBV | 1.0 |
| MA position | 9.0 |
| Volume | 0.0 |
- ▸Volume distribution (falling OBV)
- ▸Above 200-day MA
Sentiment
6.6/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 7.2 |
| Price target | 7.5 |
| erm sentiment | 4.6 |
Insider
5.1/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.2 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
Peer rank
3.7/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 5.4 |
| quality rank | 7.2 |
| growth rank | 2.1 |
Technical
4.6/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 3.2 |
| support resistance | 3.4 |
| 52w position | 6.9 |
| gap | 5.0 |
Risk (lower is worse)
4.0/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 6.3 |
| days to cover | 6.2 |
| volatility | 1.9 |
| put call | 0.0 |
| implied vol | 4.1 |
| max pain risk | 7.0 |
| beta | 4.4 |
| debt equity | 2.2 |
- ▸Elevated put/call: 2.45
- ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
5.7/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 6.1 |
- ▸Strong earnings: 3B/1M
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (7)
- MOMENTUM:4.8>=4.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:34d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:0.3<1.5@spot
Warning (1)
- MOMENTUM:4.8<5.5 (soft — BUY_NOW allowed but watch)
Reward-to-Risk
0.33
Upside
+3.0%
Downside
9.2%
Sizing output
AVOID
SetupBREAKOUT — Golden cross, above all MAs, RSI 56, MACD bullish
EdgeNO_EDGE — No clear edge identified
SuitabilityAGGRESSIVE — Beta 1.67>1.3
Investment implication
The F-path SELL output reflects an overall score of 3.9 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Sentiment at 6.6) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:0.3<1.5@spot) reinforce the read. Current asymmetry R:R is 0.33 — supplementary context, not the trigger for this path.
The strongest dimensions are Sentiment at 6.6, Value at 6.5, and Quality at 6.1; the weakest are Peer rank at 3.7, Risk (lower is worse) at 4.0, and Technical at 4.6. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of 0.33 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1The company has beaten analyst earnings estimates in each of the 3 most recent quarters, with average positive surprises of roughly 10%, demonstrating a track record of managing and beating investor expectations consistently.
Trip ifEPS surprise falls below 0% for 2 consecutive quarters.
- P2The business converts 125% of net income into free cash flow, indicating that reported earnings likely understate the true economic cash the business generates; this quality advantage supports balance-sheet optionality for buybacks or debt reduction.
Trip ifFree-cash-flow-to-net-income ratio falls below 80% for 2 consecutive quarters.
- P3Approximately 80% of revenues are tied to the clear aligner segment, creating concentrated exposure to a single product category; any sustained shift in orthodontic treatment volumes or competitive pricing pressure in that segment would have outsized impact on overall results.
Trip ifNon-aligner segment revenue grows above 25% of total revenue for 2 consecutive quarters.
- P4With approximately 2% remaining to the analyst consensus price target and a put-to-call ratio of 1.36 indicating above-average bearish options positioning, the near-term reward-to-risk geometry does not support new entry at current levels.
Trip ifAnalyst consensus price target exceeds the current price by more than 10%, restoring meaningful upside headroom.